FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378172496> ?p ?o ?g. }

• W4378172496 endingPage "1049" @default.
• W4378172496 startingPage "1041" @default.
• W4378172496 abstract "Type 2 targeting biologics have reached the market first for asthma and since 2019 also for CRSwNP. As clear guidelines and predictors for optimal biological choice are missing, patients are sometimes required to switch biologic therapy in order to find the optimal treatment result. In this paper, we evaluate reasons for switching biologics and the treatment effects after each sequential switch.Ninety-four patients who switched from one biologic to another for their treatment of CRSwNP and asthma were evaluated.Twenty patients experienced satisfactory control of CRSwNP, but insufficient control of severe asthma. Fifty-one patients experienced satisfactory control of severe asthma, but insufficient control of CRSwNP/EOM. Twenty-eight patients experienced insufficient control of both upper and lower airways. Thirteen patients had to switch because of side effects. Furthermore, two cases are described to clarify clinical decision-making.For abovementioned patients, a multidisciplinary approach is mandatory to find the best suitable biologic. It seems ineffective to switch to a second anti-IL5 treatment if the first one is not successful. Most patients that failed omalizumab and/or an anti-IL-5 treatment are well controlled on dupilumab. Therefore, we suggest to use dupilumab as first choice when switching biologic agents." @default.
• W4378172496 created "2023-05-26" @default.
• W4378172496 creator A5009630383 @default.
• W4378172496 creator A5012489995 @default.
• W4378172496 creator A5015311592 @default.
• W4378172496 creator A5023964068 @default.
• W4378172496 creator A5025863685 @default.
• W4378172496 creator A5033912543 @default.
• W4378172496 creator A5038444881 @default.
• W4378172496 creator A5049663933 @default.
• W4378172496 creator A5053635598 @default.
• W4378172496 creator A5055521008 @default.
• W4378172496 creator A5066127778 @default.
• W4378172496 creator A5088289926 @default.
• W4378172496 creator A5089892690 @default.
• W4378172496 date "2023-05-29" @default.
• W4378172496 modified "2023-10-01" @default.
• W4378172496 title "Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making" @default.
• W4378172496 cites W3004838051 @default.
• W4378172496 cites W3009076370 @default.
• W4378172496 cites W3034315108 @default.
• W4378172496 cites W3107029065 @default.
• W4378172496 cites W3126529260 @default.
• W4378172496 cites W3131670476 @default.
• W4378172496 cites W3135702916 @default.
• W4378172496 cites W3200207529 @default.
• W4378172496 cites W3207497551 @default.
• W4378172496 cites W3214550617 @default.
• W4378172496 cites W4200320518 @default.
• W4378172496 cites W4205763276 @default.
• W4378172496 cites W4226102981 @default.
• W4378172496 cites W4229451011 @default.
• W4378172496 cites W4280489928 @default.
• W4378172496 cites W4283767956 @default.
• W4378172496 cites W4311175873 @default.
• W4378172496 cites W4313014204 @default.
• W4378172496 doi "https://doi.org/10.1080/1744666x.2023.2218617" @default.
• W4378172496 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37226507" @default.
• W4378172496 hasPublicationYear "2023" @default.
• W4378172496 type Work @default.
• W4378172496 citedByCount "0" @default.
• W4378172496 crossrefType "journal-article" @default.
• W4378172496 hasAuthorship W4378172496A5009630383 @default.
• W4378172496 hasAuthorship W4378172496A5012489995 @default.
• W4378172496 hasAuthorship W4378172496A5015311592 @default.
• W4378172496 hasAuthorship W4378172496A5023964068 @default.
• W4378172496 hasAuthorship W4378172496A5025863685 @default.
• W4378172496 hasAuthorship W4378172496A5033912543 @default.
• W4378172496 hasAuthorship W4378172496A5038444881 @default.
• W4378172496 hasAuthorship W4378172496A5049663933 @default.
• W4378172496 hasAuthorship W4378172496A5053635598 @default.
• W4378172496 hasAuthorship W4378172496A5055521008 @default.
• W4378172496 hasAuthorship W4378172496A5066127778 @default.
• W4378172496 hasAuthorship W4378172496A5088289926 @default.
• W4378172496 hasAuthorship W4378172496A5089892690 @default.
• W4378172496 hasBestOaLocation W43781724961 @default.
• W4378172496 hasConcept C126322002 @default.
• W4378172496 hasConcept C141105273 @default.
• W4378172496 hasConcept C159654299 @default.
• W4378172496 hasConcept C177713679 @default.
• W4378172496 hasConcept C187212893 @default.
• W4378172496 hasConcept C203014093 @default.
• W4378172496 hasConcept C2776042228 @default.
• W4378172496 hasConcept C2776178081 @default.
• W4378172496 hasConcept C2776238763 @default.
• W4378172496 hasConcept C2777714996 @default.
• W4378172496 hasConcept C2778564945 @default.
• W4378172496 hasConcept C2779824493 @default.
• W4378172496 hasConcept C2781390199 @default.
• W4378172496 hasConcept C3020633164 @default.
• W4378172496 hasConcept C71924100 @default.
• W4378172496 hasConceptScore W4378172496C126322002 @default.
• W4378172496 hasConceptScore W4378172496C141105273 @default.
• W4378172496 hasConceptScore W4378172496C159654299 @default.
• W4378172496 hasConceptScore W4378172496C177713679 @default.
• W4378172496 hasConceptScore W4378172496C187212893 @default.
• W4378172496 hasConceptScore W4378172496C203014093 @default.
• W4378172496 hasConceptScore W4378172496C2776042228 @default.
• W4378172496 hasConceptScore W4378172496C2776178081 @default.
• W4378172496 hasConceptScore W4378172496C2776238763 @default.
• W4378172496 hasConceptScore W4378172496C2777714996 @default.
• W4378172496 hasConceptScore W4378172496C2778564945 @default.
• W4378172496 hasConceptScore W4378172496C2779824493 @default.
• W4378172496 hasConceptScore W4378172496C2781390199 @default.
• W4378172496 hasConceptScore W4378172496C3020633164 @default.
• W4378172496 hasConceptScore W4378172496C71924100 @default.
• W4378172496 hasIssue "8" @default.
• W4378172496 hasLocation W43781724961 @default.
• W4378172496 hasLocation W43781724962 @default.
• W4378172496 hasOpenAccess W4378172496 @default.
• W4378172496 hasPrimaryLocation W43781724961 @default.
• W4378172496 hasRelatedWork W2185828908 @default.
• W4378172496 hasRelatedWork W2984771423 @default.
• W4378172496 hasRelatedWork W3092367507 @default.
• W4378172496 hasRelatedWork W3119831431 @default.
• W4378172496 hasRelatedWork W4242272757 @default.
• W4378172496 hasRelatedWork W4285591439 @default.
• W4378172496 hasRelatedWork W4293148000 @default.

• next